WORK Medical Strengthens Nasdaq Compliance via Reverse Split
HANGZHOU, China | December 24, 2025 — WORK Medical Technology Group LTD, a China-based supplier of Class I and...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HANGZHOU, China | December 24, 2025 — WORK Medical Technology Group LTD, a China-based supplier of Class I and...
December 22, 2025 | Abbott Park, Illinois — Abbott announced that the U.S. Food and Drug Administration (FDA) has...
ALACHUA, Fla. and TAMPA, Fla., Dec. 17, 2025 — Axogen, Inc. (NASDAQ: AXGN), a recognized leader in peripheral nerve...
RAHWAY, N.J. — December 3, 2025 — Mexico’s Secretariat of Agriculture and Rural Development (SADER) has granted approval for...
Minneapolis, MN — December 3, 2025 — Medtronic announced that the U.S. Food and Drug Administration (FDA) has granted...
MINNEAPOLIS & BRISBANE, May 13, 2025—Anteris Technologies Global Corp. announced its first-quarter 2025 results, revealing significant progress across clinical...
LISLE, Ill., Nov. 12, 2025—Hubly Surgical announced that its Hubly Auto-Stop Drill has received FDA 510(k) clearance expanding the...
SOUTH ORANGE, N.J., November 6, 2025 — Nephros, Inc. (Nasdaq: NEPH), a leader in water filtration solutions for the...
COPENHAGEN, November 6, 2025 — GN Store Nord A/S (GN) reported a strong Q3 2025 performance, achieving 1% organic...
CHELMSFORD, Mass., Sept. 30, 2025 — The U.S. Food and Drug Administration (FDA) has approved the ZOLL Zenix Monitor/Defibrillator,...
